Platelet: transporter of vascular endothelial growth factor.
暂无分享,去创建一个
H. Verheul | C. Folman | H. Pinedo | H. Broxterman | K. Hoekman | C. Eekman | S. L. Luykx-de Bakker | S. D. Bakker | M. W. Verheul | Cornelis A. Eekman
[1] K. Alitalo,et al. Serum vascular endothelial growth factor is often elevated in disseminated cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] W. Jelkmann,et al. Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. , 1997, International journal of oncology.
[3] S. Rafii,et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] O. Vinante,et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. , 1997, Journal of the National Cancer Institute.
[5] K. Kaushansky. Thrombopoietin the primary regulator of platelet production. , 1995, Trends in endocrinology and metabolism: TEM.
[6] G. Gasparini. Clinical significance of the determination of angiogenesis in human breast cancer: update of the biological background and overview of the Vicenza studies. , 1996, European journal of cancer.
[7] M. Klagsbrun,et al. Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.
[8] N. Milman,et al. Prognostic significance of thrombocytosis in patients with primary lung cancer. , 1996, The European respiratory journal.
[9] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[10] M. Toi,et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] R. Williamson,et al. Thromboprophylaxis in malignant disease , 1995, The British journal of surgery.
[12] A. Harris,et al. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Kondo,et al. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. , 1994, Biochimica et biophysica acta.
[14] M. Young,et al. Granulocyte‐macrophage colony‐stimulating factor stimulates the metastatic properties of lewis lung carcinoma cells through a protein kinase a signal‐transduction pathway , 1993, International journal of cancer.
[15] J. Richie,et al. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. , 1993, Journal of the National Cancer Institute.
[16] F Pozza,et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.
[17] A. Harris,et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.
[18] J. Wagstaff,et al. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer. , 1991, Journal of the National Cancer Institute.
[19] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[20] J. V. van Mourik,et al. A Monoclonal Antibody to the Human Platelet Glycoprotein II b/III a Complex Induces Platelet Activation , 1988, Thrombosis and Haemostasis.
[21] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[22] J. Folkman. Tumor angiogenesis. , 1985, Advances in cancer research.
[23] S. Karpatkin,et al. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. , 1984, Cancer research.
[24] R. Weinberg,et al. A molecular basis of cancer. , 1983, Scientific American.
[25] C. Schmidt,et al. Oral anticoagulation in the treatment of a spontaneously metastasising murine tumour (3LL). , 1977, British Journal of Cancer.
[26] L. Harker,et al. Platelet and fibrinogen consumption in man , 1973 .
[27] C. Stewart,et al. Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.